Evercore ISI Reaffirms Their Buy Rating on BioCryst (BCRX)
Evercore ISI analyst Liisa Bayko maintained a Buy rating on BioCryst (BCRX – Research Report) today and set a price target of $10.00. The ...
RBC Capital Reaffirms Their Buy Rating on BioCryst (BCRX)
In a report released yesterday, Brian Abrahams from RBC Capital maintained a Buy rating on BioCryst (BCRX – Research Report), with a ...